potency printed on the label. Scientus
Pharma’s new product line, on the other hand,
will utilize a newly patented extraction
process that it believes is going to
revolutionize the world of cannabis medicine.
The company claims it can achieve 99.9
percent decarboxylate in every batch.
A representative from Health Canada, the
agency responsible for overseeing the
country’s medical marijuana program, told
VICE that cannabis extracts are “subject to
some of the most stringent requirements in the
world.” The problem, they countered, is that
licensed producers are responsible for their
own testing, either in-house or through a third
party source.
This leaves plenty of room for discrepancies
to emerge.
Nevertheless, the Canadian cannabis industry
is sceptical about the study’s claims,
attributing the research and its subsequent
release to “corporate strategy.”
They argued that although THC and CBD
levels can fluctuate from time to time
depending on the source, what is printed on
the labels is accurate.
Some believe the discrepancies are likely due
to human error and not direct evidence that the
medical marijuana being sold in Canada is an
outright sham.
But no one in the industry is going to admit
that they are providing patients with cannabis
that has little to no strength, especially
considering that hundreds of thousands of
patients claim to receive immense therapeutic
benefits from these extracts.
But the Scientus Pharma research suggests —
dare we say — that the placebo effect is in full
swing in the northern nation.
What a kick in the pants it would be to learn,
after all these years, that Canada’s medical
marijuana sector is just now on the verge of
producing effective cannabis extracts.
For what it’s worth, patient advocate Tracey
Curley told VICE that the word on the street
is the Scientus Pharma study is on the money.
“I’ve certainly heard of a discrepancy in
dosage depending on what product client is
using even though the label says that they are
very similar,” she said to the news source.